Citations

Citations to this article as recorded by  

• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
  Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Hepatology International.2025; 19(4): 959.     CrossRef
• Long-Term Safety and Efficacy of Tenofovir Alafenamide in Chronic Hepatitis B: Raising the Need for Studies on Functional Cure—Editorial on “Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B”
  Soon Kyu Lee
  The Korean Journal of Gastroenterology.2025; 85(3): 245.     CrossRef
• Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
  Jeong‐Ju Yoo, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Min Jae Kim
  Journal of the International AIDS Society.2024;[Epub]     CrossRef
• Tenofovir Alafenamide for Multiple Drug-Resistant Chronic Hepatitis B: A 3-Year Clinical Trial
  Jonggi Choi, Young-Suk Lim, Ji-Hoon Kim, Kwan Soo Byun, Byung Chul Yoo
  Clinical Gastroenterology and Hepatology.2023; 21(12): 3185.     CrossRef
• Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
  Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Hepatology International.2023; 17(4): 860.     CrossRef
• Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
  Jonggi Choi, Won-Mook Choi, Young-Suk Lim
  Clinics in Liver Disease.2023; 27(4): 809.     CrossRef